Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pierre S. who wrote (1825)	5/12/1999 7:01:00 AM
From: Mark Bartlett	of 14101

Pierre, <<My point is that the FDA looks at drug approval as a cost/benefit issue. >> About 16-20 thousand Americans die (and 1900 Canadians) each year due to GI bleeds and other oral NSAID complications. If this number can be decreased with a product like Pennsaid - and there are no serious side-effects (which appears to be the case) this would seem to imply a decent cost/benefit by using the product. DMSO has been used for years by many athletes in amounts far exceeding what is used in Pennsaid - the drug got a bad wrap from the get-go for no real scientifically valid reason. The FDA themselves have admitted publicly there is no evidence DMSO causes any serious side-effects - and the stuff has been around for decades. Do a search using the terms DMSO and you will be amazed at what you turn up. MB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next